KALV Stock Analysis: Buy, Sell, or Hold?
KALV - KalVista Pharmaceuticals, Inc. Common Stock
$26.73
-0.03 (-0.11%)
▼
5d:
+0.0%
30d:
+36.66%
90d:
+79.28%
HOLD
MODERATE Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: Mar 24, 2026
0d
Smart Money Distribution
None View Scanner →
Strength: 7.9/10
Get Alerted When KALV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: KALV shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: KALV shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: KALV is currently trading at $26.73, which is considered extended relative to its 30-day fair value range of $19.35 to $26.25.
Technical Outlook: Technically, KALV is in a strong uptrend. The price is currently testing key support at $26.63. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: KALV has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, KALV is in a strong uptrend. The price is currently testing key support at $26.63. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: KALV has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$19.35 -
$26.25
Company Quality Score
62/100
(BUY)
Volume Confirmation
MODERATE
Confidence Score
52.6%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (60/100)
- NEUTRAL: Near Wall St target ($28.60)
Trading Range Analysis
30-Day Trading Range
$19.35 -
$26.25
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$26.63
Resistance Level
$26.85
Current Trend
Strong Uptrend
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-9.58
Wall Street Target
$28.60
(+7.0%)
Revenue Growth (YoY)
30.7%
Profit Margin
-223.2%
Share & Embed Analysis
Last updated: May 18, 2026 6:43 AM ET
Data refreshes hourly during market hours. Next update: 7:43 AM
Data refreshes hourly during market hours. Next update: 7:43 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is KALV showing a specific setup today?
Insider Activity (6 Months)
0
Buys
18
Sells
Net
INSIDERS SELLING
Recent Transactions
Brian Piekos
SELL
1862 shares
2026-04-17
Nicole Sweeny
SELL
1862 shares
2026-04-17
Paul K Audhya
SELL
2686 shares
2026-04-17
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$549 | 65 BUY |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$875 | 53 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$79 | 56 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$92 | 54 HOLD |
